GRAL.NASDAQGrail, INC

Form 4: GRAIL Director Steven Mizell Awarded Over 6,000 Deferred Stock Units

Sentiment:

Insider Transaction Report


GRAIL, Inc. Director Steven Mizell was granted 6,082 deferred stock units (DSUs) on May 29, 2025, as part of the company's 2024 Equity Incentive Plan.

Summary

  • Steven Mizell, a Director of GRAIL, Inc., acquired 6,082 Deferred Stock Units (DSUs) on May 29, 2025.
  • These DSUs were granted under GRAIL's 2024 Equity Incentive Plan and were in lieu of an equivalent number of Restricted Stock Units (RSUs).
  • Each DSU represents the right to receive one share of GRAIL common stock upon settlement.
  • The DSUs were valued at approximately $41.1 per unit at the time of grant, totaling an approximate value of $249,970.20 for the award.
  • Following this transaction, Mr. Mizell's direct beneficial ownership of GRAIL common stock, including DSUs, stands at 35,685 units.
  • The DSUs will vest in full on the earlier of May 29, 2026, or the date of the next annual meeting of the Company's stockholders, contingent on Mr. Mizell's continued service.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally a positive signal as it aligns management's interests with shareholders. It's a routine compensation event, not indicative of major operational changes, hence a moderately positive score.

Positives

  • The grant of Deferred Stock Units to Director Steven Mizell aligns his interests with those of shareholders, incentivizing long-term performance and retention.
  • The award is part of the company's established 2024 Equity Incentive Plan, indicating a structured approach to executive compensation.

Negatives

  • No direct negative implications are apparent from this routine equity compensation grant to a director.

Risks

  • The vesting of the DSUs is subject to continued service, meaning Mr. Mizell must remain with the company until the applicable vesting date to receive the shares.
  • The value of the DSUs upon settlement is dependent on the future market price of GRAIL common stock, introducing market risk.

Future Outlook

The Deferred Stock Units granted to Director Steven Mizell are scheduled to vest in full on the earlier of May 29, 2026, or the date of the next annual meeting of the Company's stockholders, contingent upon his continued service to GRAIL, Inc.

Industry Context

The granting of equity awards like Deferred Stock Units (DSUs) is a standard practice in the biotechnology and healthcare industries for compensating and retaining key executives and directors. This aligns with common corporate governance practices aimed at linking executive incentives to long-term shareholder value.

Stakeholder Impact

  • Shareholders: Positive impact due to increased alignment of director's interests with long-term shareholder value through equity ownership.
  • Employees: No direct impact on general employees from this specific director compensation event.

Next Steps

  • Continued service of Steven Mizell to GRAIL, Inc. until the vesting date.
  • Vesting of the 6,082 DSUs on the earlier of May 29, 2026, or the date of the next annual meeting of stockholders.
  • Settlement of DSUs into common stock shares upon vesting.

Key Dates

DateDescription
05/29/2025Date of DSU grant to Steven Mizell.
05/29/2026Earliest potential vesting date for the DSUs, subject to continued service.

Keywords

GRAIL Inc., GRAL, SEC Form 4, Deferred Stock Units, DSU, Equity Incentive Plan, Executive Compensation, Director Compensation, Insider Transaction, Stock Award

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.